One-Step, Low-Cost, Operator-Friendly, and Scalable Procedure to Synthetize Highly Pure <i>N</i>-(4-ethoxyphenyl)-retinamide in Quantitative Yield without Purification Work-Up
It is widely reported that <i>N</i>-(4-hydroxyphenyl)-retinamide or fenretinide (4-HPR), which is a synthetic amide of all-trans-retinoic acid (ATRA), inhibits in vitro several types of tumors, including cancer cell lines resistant to ATRA, at 1–10 µM concentrations. Additionally, studie...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/11/3632 |